Search All News
A new study estimates that more than 2 million Americans with heart disease have used marijuana, but the cardiovascular effects of the drug are not fully understood.
Social support may help offset the negative impact that discrimination and gender expectations have on heart disease and stroke risk factors among transgender and gender non-conforming adults.
A new study of nearly 5 million patients shows the most-popular first-line treatment for hypertension is less effective and causes more side effects than thiazide diuretics.
Sitting while watching television, but not sitting at work, is associated with a greater risk of heart attack, stroke, or early death, Columbia researchers have found.
- September 28, 2016
Columbia researchers are enrolling women in a new study to learn if inadequate sleep increases risk of heart disease.
- September 22, 2016
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
- August 24, 2016
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy.
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
- May 26, 2016
Wearing a 24-hour monitoring device may help identify African-Americans who have masked hypertension.
- May 25, 2016
A large study found a positive correlation between traffic-related air pollution and the amount of calcium deposited in the coronary arteries.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
- May 15, 2016
Lowering blood pressure goals for people with cardiovascular risk factors could save tens of thousands of lives annually and reduce costs.
- April 2, 2016
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.